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Twenty-five years ago, Helicobacter pylori was identified as the causative agent of gastric disorders,
ranging from acute inflammation, ulceration of the stomach and duodenum, lymphoma of the MALT
(mucosa-associated lymphoid tissue) system and gastric cancer. First assigned as Campylobacter pylori,
the bacterium was finally renamed Helicobacter pylori and defined as the type species of a novel genus
after 16S rRNA sequencing. The identification of H. pylori revolutionized the treatment of gastric
disorders since bacterial eradication can eliminate the root of diseases. The initial contact with H. pylori
normally occurs in early childhood and infection persists life-long as the immune system cannot
efficiently combat the bacterium. As a consequence of the close association of H. pylori infection and
gastric cancer, the International Agency for Research on Cancer (IARC) classified H. pylori as a class-I
carcinogen in 1994. Treatment with antibiotics is still the only option to prevent H. pylori-associated
diseases. Antibiotic therapy has been established as the standard of care in MALT lymphoma patients
and can result in complete disappearance of early-stage MALT lymphoma of the stomach. The outcome
of the disease is strongly dependent on genetic predispositions of the host, but also on the expression of
different bacterial virulence factors, including adhesins, outer membrane proteins (OMPs), proteases,
type-IV secretion system (T4SS), cytotoxin-associated gene A (CagA), or vacuolating toxin A (VacA).
In this Special Issue, a collection of review and research articles is presented to provide a deep
insight into how H. pylori interferes with host cells to drive the cells toward inflammatory and
carcinogenic responses.
The recent knowledge about H. pylori-mediated gastric MALT lymphoma (GML) has been
summarized by Floch and colleagues [1]. So far, GML has not been associated with individual H. pylori
virulence factors. However, a unique Lewis antigen profile in GML strains is possibly implicated in the
immune evasion and activation of infiltrating lymphocytes. Similar to MALT lymphoma, the induction
and progression of gastric cancer is a multi-step process controlled by a complex interaction between
bacterial and host factors. Disruption and depolarization of the gastric epithelium is a hallmark of
gastric cancer. Within the complex processes leading to tissue destruction, a controlled proteolysis of
epithelial cell surface structure is required which can be directly influenced by H. pylori. The proteolytic
modulation of extracellular matrix (ECM) proteins, cell surface receptors, membrane-bound cytokines,
membrane-bound epidermal growth factor receptor ligands and lateral adhesion molecules involves
H. pylori-regulated proteases of the host and of bacterial origin. In the review of Posselt et al., the
mechanisms of host matrix-metalloproteinases (MMPs), a disintegrin and metalloproteinases (ADAMs),
tissue inhibitors of metalloproteinases (TIMPs), and the bacterial secreted proteases Hp0169 and high
temperature requirement A (HtrA) were described and how they facilitate the disruption of the
epithelial barrier [2]. Among H. pylori virulence factors, VacA expression has been connected with
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H. pylori pathogenesis. McClain and colleagues give an overview on epidemiologic studies showing
an association between specific vacA allelic types and gastric cancer and discuss the mechanisms
by which VacA-induced cellular alterations may contribute to the pathogenesis of gastric cancer [3].
A specialized T4SS is exposed by H. pylori which translocates CagA into host cells. Independently of
CagA injection into epithelial cells, the T4SS is crucially important to induce nuclear factor kappa B
(NF-κB) activity; a main driver of cytokine, growth factor, anti-apoptosis regulators or metalloprotease
expression. Sokolova and Naumann provide a comprehensive overview about mechanisms and
consequences of NF-κB activation in gastric carcinogenesis [4]. OMPs were described as essential
molecules to promote CagA translocation into gastric cells via the T4SS of H. pylori. The review by
Matsuo et al. summarizes the cellular processes through which H. pylori utilizes OMPs to colonize the
human stomach and how OMPs cooperate with the T4SS [5].
The T4SS-mediated CagA delivery into host cells is considered as a hallmark in H. pylori
pathogenesis and gastric carcinogenesis. An overview on the epidemiology of CagA-positive H. pylori
and gastric cancer has been provided by Park et al. [6]. Meta-analyses indicated that CagA positive
infections increase the risk of gastric cancer two-fold underlining the importance on population-based
H. pylori screening and treatment strategies. The molecular mechanism of CagA translocation and
the subsequent signal transduction pathways have been reviewed by Tegtmeyer et al. [7]. The T4SS
represents an extracellular pilus-like structure exposing CagI, CagL, CagY, and CagA to target the
integrin-β1 receptor as a prerequisite for translocation of CagA. Translocated CagA is finally tyrosine
phosphorylated by oncogenic host cellular Src and Abl kinase activities. CagA then interacts with
several host signalling proteins in phosphorylation-dependent and phosphorylation-independent
fashions. The contribution of these interactions to H. pylori colonization, signal transduction, and
gastric pathogenesis has been included in this review [7]. The interaction of CagA with eukaryotic
signalling proteins of the host has been described in more detail by Nishikawa and Hatakeyama.
The intrinsically disordered C-terminal part of CagA contains the Glu-Pro-Ile-Tyr-Ala (EPIYA) motif
and the CagA multimerization (CM) motif. Dependent on tyrosine phosphorylation, the EPIYA motif
binds and deregulates Src homology 2 domain-containing protein tyrosine phosphatase 2 (SHP2),
which is important in inducing pro-oncogenic mitogenic signalling and abnormal cell morphology.
Through the CM motif, CagA inhibits the kinase activity of polarity regulator partitioning-defective 1b
(PAR1b), causing junctional and polarity defects while inducing actin cytoskeletal rearrangements [8].
Further, the research article by Tohidpour and colleagues identified a middle region of CagA which is
sufficient to induce its own uptake and rearrangement of the actin cytoskeleton [9].
H. pylori is a unique pathogen that colonizes the human stomach persistently. A multitude of
virulence factors has been identified in the last decades, which are implicated in pathogenesis. In this
special issue, the current knowledge of how these virulence factors interfere with the gastric epithelium
providing a comprehensive overview on the molecular and cellular mechanisms leading to chronic
inflammation and neoplasia.
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